Read, Learn, Innovate: Top Blog Posts from November 2019
ISPE
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from November 2019. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last month.
The GAMP® Global Leadership strongly supports a patient-centric and quality risk-based approach to the assurance of computerized systems. Explore the incorporation of innovative computerized technologies and approaches that advance pharmaceutical production to support product quality, patient safety, and data integrity.
See the ICH Q12 regulatory guideline, featuring detailed instruction for the break-down of complex regulation and other challenges facing the pharmaceutical industry. Professionals can adjust current production and develop new operations for excellence with the support of these management strategies.
Discover the most common violations to avoid for the implementation of a cleaning validation program in today’s industry with product-specific operations, sterile manufacturing, and how to organize pre-approved strategies. In addition, solutions to these common pitfalls are featured in this article.
Kerren Bergman, Vice President US Operations and Global HR for Hyde Engineering, discusses a crucial reminder for women to stop apologizing and be more confident in their opinions. She examines how to build your personal power, and fully understand the impact of your words in professional settings. Learn how to strengthen your voice and communicate your valuable opinions!
Read highlights from the 2019 ISPE Annual Meeting and Expo where the 2020-2022 Strategic Plan was introduced, and Frances Zipp was honored as the New chair for the ISPE International Board of Directors. See details for each award presented and the influential leaders in today’s pharmaceutical industry, who are included in the growing ISPE network.
ISPE delivers technical and operational solutions to support across the global pharmaceutical and biopharmaceutical industry in the manufacture of quality medicines for patients.
The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) has recently announced the adoption of the revised guideline
The outlook for the biopharmaceutical market is promising, with expectations that the market will double in the next 10 years, resulting in new therapies and advances in biopharmaceutical manufacturing. This doesn't sound like much at first, but if you consider how the market has developed over the last 20 years, a doubling in the next 10 years is very significant.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.